The 2021 Society for Investigative Dermatology (SID) Annual Meeting was recently sponsored and partially financed by Mary Kay Inc.
The corporation disclosed four $25,000 grants to researchers in the skin health and skin condition categories at this simulated conference and new skin health studies on a botanical extract that decreases inflammation from retinol via the TRPV-1 receptor.
Dr. Lucy Gildea, Mary Kay’s Chief Scientific Officer, said, “Mary Kay is a true believer in a collective partnership being critical in discovering discoveries and creativity.”
“Conferences like the annual Society for Investigative Dermatology meeting draw together the best minds in the profession who are working to promote the field’s future. Mary Kay is honored to be a member of this scientific community, and we are confident that these research grants will aid ongoing skin research efforts. We can’t wait to see what scientists find next.”
The mixture of retinol and plant-derived TRPV-1 antagonist and the anti-inflammatory botanical extract is explored in Mary Kay’s research on retinol-induced inflammation reduction. Preliminary findings indicate that erythema, edema, and dryness have all decreased.
Dr. Gildea said, “Our Research & Development team is constantly designing new skincare ideas for women all over the world.”
“Attending meetings like the SID annual meeting encourages us to learn and exchange important research so that we can look forward to provide customers with valuable benefits and amazing products.”
